Xiangxue Pharmaceutical (300147) — Capital Reinvestment Ratio
Xiangxue Pharmaceutical (300147) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥75.64 Million) in capital expenditures (CN¥5.74 Million). Check 300147 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xiangxue Pharmaceutical Capital Reinvestment Ratio (2007–2025)
This chart tracks Xiangxue Pharmaceutical's Capital Reinvestment Ratio across 19 annual periods. For the full cash flow conversion analysis, see 300147 cash flow conversion.
Annual Capital Reinvestment Ratio for Xiangxue Pharmaceutical (2007–2025)
Year-by-year Capital Reinvestment Ratio for Xiangxue Pharmaceutical from 2007 to 2025. See 300147 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥139.63 Million | CN¥21.51 Million | ▼ -92.1% |
| 2024 | 1.94x | CN¥18.17 Million | CN¥35.24 Million | ▲ +811.6% |
| 2023 | 0.21x | CN¥263.44 Million | CN¥56.03 Million | ▼ -86.8% |
| 2022 | 1.62x | CN¥227.38 Million | CN¥367.27 Million | ▼ -26.1% |
| 2021 | 2.18x | CN¥257.56 Million | CN¥562.74 Million | ▼ -20.6% |
| 2020 | 2.75x | CN¥257.18 Million | CN¥707.42 Million | ▼ -65.5% |
| 2019 | 7.96x | CN¥83.02 Million | CN¥661.09 Million | ▲ +46.6% |
| 2018 | 5.43x | CN¥91.24 Million | CN¥495.46 Million | ▼ -23.5% |
| 2017 | 7.10x | CN¥109.53 Million | CN¥777.87 Million | ▼ -28.3% |
| 2016 | 9.91x | CN¥198.48 Million | CN¥1.97 Billion | ▲ +471.9% |
| 2015 | 1.73x | CN¥159.89 Million | CN¥276.95 Million | ▲ +17.6% |
| 2014 | 1.47x | CN¥165.58 Million | CN¥243.85 Million | ▲ +51.8% |
| 2013 | 0.97x | CN¥328.37 Million | CN¥318.55 Million | ▼ -72.4% |
| 2012 | 3.52x | CN¥118.91 Million | CN¥418.12 Million | ▼ -55.0% |
| 2011 | 7.81x | CN¥29.55 Million | CN¥230.69 Million | ▲ +524.1% |
| 2010 | 1.25x | CN¥45.47 Million | CN¥56.87 Million | ▲ +9.3% |
| 2009 | 1.14x | CN¥46.19 Million | CN¥52.86 Million | ▼ -53.7% |
| 2008 | 2.47x | CN¥55.72 Million | CN¥137.71 Million | ▲ +135.7% |
| 2007 | 1.05x | CN¥138.02 Million | CN¥144.73 Million | — |